City

Bethesda (1)

Condition

Graft Versus Host Disease (1)

JNS Kinase (1)

Topical Administration (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)

Collaborator

Intervention

ruxolitinib 1.5% cream (1)

vehicle cream (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

jns kinase

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

Terminated

Graft Versus Host Disease
+2 more

Ruxolitinib 1.5% cream
vehicle cream

Bethesda, Maryland

National Institutes of Health Clinical Center

Jun 21, 2022